Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study
- PMID: 28446653
- PMCID: PMC5440238
- DOI: 10.1212/WNL.0000000000003961
Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study
Abstract
Objective: To examine whether vagotomy decreases the risk of Parkinson disease (PD).
Methods: Using data from nationwide Swedish registers, we conducted a matched-cohort study of 9,430 vagotomized patients (3,445 truncal and 5,978 selective) identified between 1970 and 2010 and 377,200 reference individuals from the general population individually matched to vagotomized patients by sex and year of birth with a 40:1 ratio. Participants were followed up from the date of vagotomy until PD diagnosis, death, emigration out of Sweden, or December 31, 2010, whichever occurred first. Vagotomy and PD were identified from the Swedish Patient Register. We estimated hazard ratios (HRs) with 95% confidence intervals (CIs) using Cox models stratified by matching variables, adjusting for country of birth, chronic obstructive pulmonary disease, diabetes mellitus, vascular diseases, rheumatologic disease, osteoarthritis, and comorbidity index.
Results: A total of 4,930 cases of incident PD were identified during 7.3 million person-years of follow-up. PD incidence (per 100,000 person-years) was 61.8 among vagotomized patients (80.4 for truncal and 55.1 for selective) and 67.5 among reference individuals. Overall, vagotomy was not associated with PD risk (HR 0.96, 95% CI 0.78-1.17). However, there was a suggestion of lower risk among patients with truncal vagotomy (HR 0.78, 95% CI 0.55-1.09), which may be driven by truncal vagotomy at least 5 years before PD diagnosis (HR 0.59, 95% CI 0.37-0.93). Selective vagotomy was not related to PD risk in any analyses.
Conclusions: Although overall vagotomy was not associated the risk of PD, we found suggestive evidence for a potential protective effect of truncal, but not selective, vagotomy against PD development.
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
Comment in
-
Preventing Parkinson disease by vagotomy: Fact or fiction?Neurology. 2017 May 23;88(21):1982-1983. doi: 10.1212/WNL.0000000000003969. Epub 2017 Apr 26. Neurology. 2017. PMID: 28446643 No abstract available.
Similar articles
-
Vagotomy and subsequent risk of Parkinson's disease.Ann Neurol. 2015 Oct;78(4):522-9. doi: 10.1002/ana.24448. Epub 2015 Jul 17. Ann Neurol. 2015. PMID: 26031848
-
Vagotomy and subsequent risk of inflammatory bowel disease: a nationwide register-based matched cohort study.Aliment Pharmacol Ther. 2020 Jun;51(11):1022-1030. doi: 10.1111/apt.15715. Epub 2020 Apr 22. Aliment Pharmacol Ther. 2020. PMID: 32319125
-
Dementia and vagotomy in Taiwan: a population-based cohort study.BMJ Open. 2018 Mar 30;8(3):e019582. doi: 10.1136/bmjopen-2017-019582. BMJ Open. 2018. PMID: 29602843 Free PMC article.
-
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.Lancet. 2020 Jan 11;395(10218):123-131. doi: 10.1016/S0140-6736(19)32545-0. Lancet. 2020. PMID: 31929014
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Microglial and Macrophage Plasticity and Regional Cerebral Blood Flow in the Prenatal Brain and Gut Under Vagus Nerve Stimulation.Methods Mol Biol. 2025;2868:285-301. doi: 10.1007/978-1-0716-4200-9_15. Methods Mol Biol. 2025. PMID: 39546236
-
Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice.Acta Neuropathol Commun. 2024 May 14;12(1):75. doi: 10.1186/s40478-024-01766-3. Acta Neuropathol Commun. 2024. PMID: 38745295 Free PMC article.
-
Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study.Front Immunol. 2024 Apr 25;15:1347415. doi: 10.3389/fimmu.2024.1347415. eCollection 2024. Front Immunol. 2024. PMID: 38736878 Free PMC article.
-
Epidemiology of Parkinson's Disease: An Update.Curr Neurol Neurosci Rep. 2024 Jun;24(6):163-179. doi: 10.1007/s11910-024-01339-w. Epub 2024 Apr 20. Curr Neurol Neurosci Rep. 2024. PMID: 38642225 Review.
-
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults.NPJ Parkinsons Dis. 2024 Apr 13;10(1):83. doi: 10.1038/s41531-024-00697-z. NPJ Parkinsons Dis. 2024. PMID: 38615030 Free PMC article.
References
-
- Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2015;14:625–639. - PubMed
-
- Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121–134. - PubMed
-
- Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517–536. - PubMed
-
- Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol 2010;9:1128–1138. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical